JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2015, 64(6):264-268 | DOI: 10.36290/csf.2015.062

Body surface area and body weight of Czech adult cancer population

Roman Goněc1,2,*, Irena Macků1,2, Iveta Selingerová3,4, ©árka Kozáková1
1 Hospital Pharmacy, Masaryk Memorial Cancer Institute, Brno, Czech Republic
2 Faculty of Pharmacy, Veterinary and Pharmaceutical University Brno, Czech Republic
3 RECAMO, Masaryk Memorial Cancer Institute, Brno, Czech Republic
4 Department of Mathematics and Statistics, Faculty of Science, Masaryk University, Brno, Czech Republic

Almost all conventional cytostatics are dosed according to body surface area of the patient. Many monoclonal antibodies are also dosed with respect to body surface area or body weight of the patient. While in some European countries, there is recent information describing the anthropometrics of the cancer population, no data are available for Czech population. That is the reason why body surface area and weight of adult patients who were administered chemotherapy at Masaryk Memorial Cancer Institute in 2013 and 2014 were evaluated. The total number of evaluated patients was 3873, consisting of 2476 women and 1397 men. The mean body surface area was 1.78 m2 (95% confidence interval (CI) 1.77-1.79 m2) for women, 2.00 m2 (95% CI 1.99-2.01 m2) for men, and 1.86 m2 (95% CI 1.85-1.87 m2) in total. The mean body weight was 71.94kg for women (95% CI 71.35-72.53 kg), 83.43kg (95% CI 82.60-84.26 kg) for men, and 76.09kg (95% CI 75.58-76.60 kg) in total.

Keywords: body surface area; body weight; chemotherapy;
Grants and funding:

Supported by the project MEYS-NPS I-LO1413.

Received: September 29, 2015; Accepted: November 12, 2015; Published: June 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Goněc R, Macků I, Selingerová I, Kozáková ©. Body surface area and body weight of Czech adult cancer population. Čes. slov. farm. 2015;64(6):264-268. doi: 10.36290/csf.2015.062.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kaestner S. A., Sewell G. J. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area. Clin. Oncol. (R. Coll. Radiol.) 2007; 19, 23-37. doi:10.1016/j.clon.2006.10.010 Go to original source... Go to PubMed...
    2. Calvert A. H., Newell D. R., Gumbrell L. A., O'Reilly S., Burnell M., Boxall F. E., Siddik Z. H., Judson I. R., Gore M. E., Wiltshaw E. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J. Clin. Oncol. 1989; 7, 1748-1756. Go to original source... Go to PubMed...
    3. Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1), 31-41. Go to original source... Go to PubMed...
    4. Sawyer M., Ratain M. J. Body surface area as a determinant of pharmacokinetics and drug dosing. Invest New Drugs 2001; 19, 171-177. doi:10.1023/A:1010639201787 Go to original source... Go to PubMed...
    5. Undevia S. D., Gomez-Abuin G., Ratain M. J. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer 2005; 5, 447-458. doi:10.1038/nrc1629 Go to original source... Go to PubMed...
    6. Gurney H. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative. J. Clin. Oncol. 1996; 14, 2590-2611. Go to original source... Go to PubMed...
    7. Felici A., Verweij J., Sparreboom A. Dosing strategies for anticancer drugs: The good, the bad and body-surface area. Eur. J. Cancer 2002; 38, 1677-1684. doi:10.1016/S0959-8049(02)00151-X Go to original source... Go to PubMed...
    8. Mathijssen R. H. J., de Jong F. A., Loos W. J., van der Bol J. M., Verweij J., Sparreboom A. Flat-fixed dosing versus body surface area-based dosing of anticancer drugs in adults: does it make a difference? The Oncologist 2007; 12(8), 913-923. doi:10.1634/theoncologist.12-8-913 Go to original source... Go to PubMed...
    9. Plumridge R. J., Sewell G. J. Dose-banding of cytotoxic drugs: a new concept in cancer chemotherapy. Am. J. Health Syst. Pharm. 2001; 58(18), 1760-1764. doi:10.1038/bjc.2012.357 Go to original source... Go to PubMed...
    10. Chatelut E., White-Koning M. L., Mathijssen R. H. J., Puisset F., Baker S. D., Sparreboom A. Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents. BJC 2012; 107, 1100-1106. doi:10.1038/bjc.2012.357 Go to original source... Go to PubMed...
    11. Zavery B., Marsh G. Could logarithmic dosing change the way cytotoxics are prescribed? Clinical Pharmacist 2011; 3, 116-118.
    12. DuBois D., DuBois E. F. A formula to estimate the approximate surface area if height and weight be known. Arch. Internal. Med. 1916; 17, 863-871. Go to original source...
    13. Pinkel D. The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Res. 1958; 18, 853-856.
    14. Freireich E. J., Gehan E. A., Rall D. P., Schmidt L. H., Skipper H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, dog, monkey, and man. Cancer Chemother. Rep. 1966; 50, 219-244.
    15. Wang Y., Moss J., Thisted R. Predictors of body surface area. J. Clin. Anesth. 1992; 4, 4-10. Go to original source... Go to PubMed...
    16. Boyd E. Experimental error inherent in measuring growing human body. Am. J. Physiol. 1930; 13, 389-432. Go to original source...
    17. Gehan E. A., George S. L. Estimation of human body surface area from height and weight. Cancer Chemother. Rep. 1970; 54, 225-235.
    18. Mosteller R. D. Simplified calculation of body-surface area. N. Engl. J. Med. 1987; 317, 1098. Go to original source... Go to PubMed...
    19. Lam T. K. K., Leung D. T. Y. More on simplified calculation of body surface area. N. Engl. J. Med. 1988; 318, 1130. Go to original source...
    20. Verbraecken J., Van de Heyning P., De Backer W., Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 2006; 55, 515-524. doi:10.1016/j.metabol.2005.11.004 Go to original source... Go to PubMed...
    21. Fujimoto S., Watanabe T., Sakamoto A., Yukawa K., Morimoto K. Studies on the physical surface area of Japanese. 18. Calculation formulae in three stages over all ages. Nippon Eiseigaku Zasshi 1968; 5, 443-450. Go to original source... Go to PubMed...
    22. Heaf J. G. The origin of the 1.73 m2 body surface area normalization: problems and implications. Clin. Physiol. Funct. Imaging 2007; 27(3), 135-137. doi:10.1111/j.1475-097X.2006.00718.x Go to original source... Go to PubMed...
    23. Jirkovský D. Body height and weight in young men aged 18-25 in the second half of the 20th century. Mil. Med. Sci. Lett. 2003; 72(5), 217-220.
    24. Dooley M. J., Singh S., Michael M. Implications of dose rounding of chemotherapy to the nearest vial size. Support Care Cancer 2004; 12, 653-656.
    25. Sacco J. J., Botten J., Macbeth F., Bagust A., Clark P. The average body surface area of adult cancer patients in the UK: a multicentre retrospective study. PLoS ONE 2010; 5(1), e8933. doi:10.1371/journal.pone.0008933 Go to original source... Go to PubMed...
    26. SVOD. http://www.svod.cz/?sec=aktuality〈=en, data for year 2012; access date 20th July 2015.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.